Bank of New York Mellon
BCAB icon

Bank of New York Mellon’s BioAtla BCAB Stock Holding History

Bank of New York Mellon’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,450
Closed -$421K – 4136
2024
Q1 		$421K Sell
2,450
-210
-8% -$26.1K ﹤0.01% 3632
2023
Q4 		$327K Hold
2,660
– – ﹤0.01% 3763
2023
Q3 		$226K Hold
2,660
– – ﹤0.01% 3917
2023
Q2 		$399K Buy
2,660
+2,260
+565% +$389K ﹤0.01% 3710
2023
Q1 		$53.6K Hold
400
– – ﹤0.01% 4186
2022
Q4 		$165K Buy
400
+137
+52% +$56.8K ﹤0.01% 4023
2022
Q3 		$101K Buy
+263
New +$86.1K ﹤0.01% 4194
2022
Q2 		– Sell
-1,015
Closed -$254K – 4592
2022
Q1 		$254K Hold
1,015
– – ﹤0.01% 4108
2021
Q4 		$996K Buy
1,015
+139
+16% +$178K ﹤0.01% 3390
2021
Q3 		$1.29M Buy
876
+257
+42% +$501K ﹤0.01% 3249
2021
Q2 		$1.31M Sell
619
-17
-3% -$38.4K ﹤0.01% 3249
2021
Q1 		$1.62M Buy
+636
New +$1.63M ﹤0.01% 3048

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
SAM
Scion Asset Management Saratoga, California $1.38B AUM 43.96% 1-Year Est. Return

Bank of New York Mellon's BCAB Position: Q2 2024 in Review

Bank of New York Mellon sold out of BioAtla (BCAB) in Q2 2024, closing a stake of 2,450 shares — an estimated $421K sold.

Bank of New York Mellon first reported a position in BCAB in Q1 2021 and held it in 12 quarters. The position peaked at $1.62M in Q1 2021. 80 funds tracked by Wall St. Rank hold BCAB as of Q2 2024.

  • Bank of New York Mellon reported no remaining BioAtla position as of Q2 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 2,450 BioAtla shares in Q2 2024, an estimated $421K.
  • Bank of New York Mellon first reported a position in BioAtla in Q1 2021 and held it in 12 quarters.
  • Bank of New York Mellon's BioAtla position peaked at $1.62M in Q1 2021.
  • 80 funds tracked by Wall St. Rank held BioAtla as of Q2 2024.

Based on Bank of New York Mellon's 13F filing for Q2 2024, filed 25 Jul 2024.